The operating margin has moved from 44.8% at the 2025Q3 peak to -15.5% in 2027Q1, and since SG&A ran near $84 million against a near-zero gross profit base, this reflects severe negative operating leverage rather than a one-time charge. Net margin of -10.9% is cushioned by roughly $25 million of non-operating income, which appears to be interest and other items rather than core earning power, so the true operating result is even weaker than the bottom line suggests.

The deterioration is driven by both sides of the equation: margins compressed to zero while asset turnover roughly halved, which is consistent with a fixed asset base that grew about 52% in PP&E to roughly $1.3 billion while revenue contracted 31.7% year over year. ROE of -2.2% compares with 22.9% two years earlier, so if the current earnings base persists, the cage-free buildout and goodwill additions may take several quarters of restored pricing to earn their cost of capital back.

Days of inventory outstanding rose from 39 to 65 while days payable slipped from 19 to 17, so the supplier trade credit contribution shrank exactly as inventory became harder to turn — a combination that has repeatedly appeared as a cash drain in the company's reported working capital lines. DSO has also crept from 24 to 46 days, which may indicate softer pricing has lengthened customer payment cycles, and investors should monitor whether this reflects retailer leverage or a genuine demand slowdown.

Because Cal-Maine reports zero total debt, interest coverage of -339x reflects operating losses rather than any debt service burden, so refinancing risk appears immaterial and the variable dividend policy has already shut off distributions to preserve cash. That said, a current ratio near 8x is unusually high for an industrial food producer and partly reflects inventory carried at values that may not be realizable if egg prices stay depressed, so the stress-test question is whether inventory is financeable rather than whether the ratio clears a conventional threshold.

The 0.06 PEG and 8.89x forward P/E mechanically imply a large earnings recovery, but since the forward base is not disclosed in the latest filings and management provided no fresh guidance at the 2026-09-30 report date, these figures should be read as artifacts of a depressed denominator rather than evidence of undervaluation. Against peers, the P/B of 1.19x sits close to Vital Farms' 1.17x and Limoneira's 1.11x, yet Vital Farms' ROIC of 26.9% versus Cal-Maine's -2.5% suggests the market is applying a similar book multiple to businesses with very different capital efficiency.